| DAA1973 |
5-hmC increase in cerebrellum |
Molecular |
cerebellum |
Mouse |
— |
— |
|
| DAA1 |
abhydrolase domain containing 14A |
Molecular |
brain |
Human |
ABHD14A |
3.0% Decrease Gene Expression Level |
|
| DAA2 |
abl-interactor 2 |
Molecular |
brain |
Human |
ABI2 |
18.0% Decrease Gene Expression Level |
|
| DAA3 |
actin, alpha 1, skeletal muscle |
Molecular |
brain |
Human |
ACTA1 |
16.0% Decrease Gene Expression Level |
|
| DAA4 |
actin, beta |
Molecular |
brain |
Human |
ACTB |
4.0% Decrease Gene Expression Level |
|
| DAA5 |
actin-like 6A |
Molecular |
brain |
Human |
ACTL6A |
21.0% Increase Gene Expression Level |
|
| DAA1391 |
acyl-CoA synthetase short-chain family member 1 |
Molecular |
hippocampus |
Mouse |
Acss1 |
2.0% Decrease Gene Expression Level |
|
| DAA12 |
adaptor-related protein complex 1, sigma 1 subunit |
Molecular |
brain |
Human |
AP1S1 |
12.0% Decrease Gene Expression Level |
|
| DAA6 |
AHNAK nucleoprotein |
Molecular |
brain |
Human |
AHNAK |
13.0% Increase Gene Expression Level |
|
| DAA1247 |
albumin |
Molecular |
brain |
Mouse |
Alb |
88.0% Increase Gene Expression Level |
|
| DAA7 |
aldehyde dehydrogenase 9 family, member A1 |
Molecular |
brain |
Human |
ALDH9A1 |
10.0% Increase Gene Expression Level |
|
| DAA1967 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) mRNA expression increase |
Molecular |
cerebellum |
Mouse |
— |
— |
|
| DAA1964 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
cerebellum |
Mouse |
Alox5 |
— |
|
| DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
hippocampus |
Mouse |
— |
— |
|
| DAA8 |
angiomotin |
Molecular |
brain |
Human |
AMOT |
10.0% Increase Gene Expression Level |
|
| DAA9 |
ankyrin 2, neuronal |
Molecular |
brain |
Human |
ANK2 |
20.0% Decrease Gene Expression Level |
|
| DAA1394 |
annexin A2 |
Molecular |
hippocampus |
Mouse |
Anxa2 |
8.0% Increase Gene Expression Level |
|
| DAA11 |
annexin A4 |
Molecular |
brain |
Human |
ANXA4 |
11.0% Increase Gene Expression Level |
|
| DAA22 |
antizyme inhibitor 1 |
Molecular |
brain |
Human |
AZIN1 |
11.0% Decrease Gene Expression Level |
|
| DAA1223 |
APOE promoter methylation decrease |
Molecular |
prefrontal cortex |
Human |
APOE |
— |
|
| DAA1248 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
Molecular |
brain |
Mouse |
Apobec1 |
92.0% Increase Gene Expression Level |
|
| DAA13 |
apolipoprotein D |
Molecular |
brain |
Human |
APOD |
14.0% Increase Gene Expression Level |
|
| DAA14 |
arylsulfatase A |
Molecular |
brain |
Human |
ARSA |
17.0% Increase Gene Expression Level |
|
| DAA15 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
Molecular |
brain |
Human |
ATP2A2 |
9.0% Decrease Gene Expression Level |
|
| DAA16 |
ATPase, Ca++ transporting, plasma membrane 2 |
Molecular |
brain |
Human |
ATP2B2 |
23.0% Decrease Gene Expression Level |
|